ARBITEL AM TAB

About

ARBITEL AM TAB combines Telmisartan, an angiotensin II receptor blocker (ARB), with Amlodipine, a dihydropyridine calcium channel blocker (CCB). Telmisartan works by selectively blocking the AT1 receptor, preventing angiotensin II from constricting blood vessels and stimulating aldosterone release, leading to vasodilation and reduced blood pressure. Amlodipine relaxes and widens blood vessels by inhibiting the influx of calcium ions into vascular smooth muscle cells, thereby reducing peripheral vascular resistance. This dual mechanism of action provides a synergistic antihypertensive effect, effectively lowering blood pressure and reducing the risk of cardiovascular events. It is indicated for the treatment of essential hypertension, particularly in patients who have not achieved adequate blood pressure control with monotherapy or who require combination therapy for optimal management.

Uses

• Treatment of essential hypertension.
• Management of hypertension in patients requiring combination therapy.
• Reduction of cardiovascular risk in high-risk patients.
• Prevention of stroke and myocardial infarction in hypertensive individuals.

Directions For Use

Take orally once daily, with or without food, as directed by your physician.

Benefits

• Effective and sustained blood pressure reduction.
• Reduces the risk of cardiovascular events like stroke and heart attack.
• Improved blood pressure control compared to monotherapy.
• Generally well-tolerated with a convenient once-daily dosing.
• Provides synergistic antihypertensive effects.
• May offer renal protection in certain patient populations.

Side Effects

• Dizziness or lightheadedness
• Peripheral edema (swelling of ankles/feet)
• Headache
• Fatigue
• Nausea
• Palpitations
• Hypotension
• Hyperkalemia
• Flushing
• Abdominal pain
• Muscle cramps
• Renal impairment

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may enhance the hypotensive effects, leading to increased dizziness or lightheadedness.
• Pregnancy - Contraindicated during pregnancy, especially in the second and third trimesters, due to significant risk of fetal renal dysfunction and mortality from the ARB component.
• Breastfeeding - Not recommended during breastfeeding as the active ingredients may pass into breast milk and could cause adverse effects in the nursing infant.
• Liver - Use with caution in patients with severe hepatic impairment; dose adjustment may be necessary due to altered metabolism and excretion of the components.
• Kidney - Use with caution in patients with severe renal impairment; close monitoring of kidney function and electrolytes is essential due to potential for worsening renal function.
• Lung - Generally safe for use in patients with lung conditions; however, monitor for any unusual respiratory symptoms, though not typically associated with these medications.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.